The aqueous and ethanolic extracts of C. grandis (Family: Leguminosae) were evaluated for antidiabetic activity by a glucose tolerance test, in normal rats and alloxan-induced diabetic rats. The aqueous and ethanolic extracts showed that they significantly lowered the blood glucose levels to normal in the glucose tolerance test. In alloxan-induced diabetic rats the maximum reduction in blood glucose was observed after three hours, at a dose level of 150 mg/kg of body weight. The percentage of protection given by the aqueous and ethanolic extracts was 32.72 and 46.42%, respectively. In the long-term treatment of alloxan-induced diabetic rats, the degree of protection was determined by measuring the blood glucose, cholesterol, and triglycerides on the tenth day. Both the extracts showed a significant antidiabetic activity comparable to that of glibenclamide. These results showed that the Cassia grandis possessed significant antidiabetic activity.
Assessment of the antidiabetic potential of Cassia grandis using an in vivo model
Sandesh R. Lodha,S. Joshi,B. Vyas,Mohini C. Upadhye,Megha S. Kirve,S. Salunke,S. Kadu,Manasi V. Rogye
Published 2010 in Journal of Advanced Pharmaceutical Technology & Research
ABSTRACT
PUBLICATION RECORD
- Publication year
2010
- Venue
Journal of Advanced Pharmaceutical Technology & Research
- Publication date
2010-07-01
- Fields of study
Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-22 of 22 references · Page 1 of 1
CITED BY
Showing 1-32 of 32 citing papers · Page 1 of 1